IGM Biosciences to Present at the 2020 RBC Capital Markets Global Healthcare Conference
May 12 2020 - 7:00AM
IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage
biotechnology company focused on creating and developing engineered
IgM antibodies, today announced that Fred Schwarzer, Chief
Executive Officer, will present at the 2020 RBC Capital Markets
Global Healthcare Conference on Tuesday, May 19 at 4:15 p.m. ET.
The conference will be held in a virtual meeting format.
A live webcast of the event will be available on the “Events and
Presentations” page in the “Investors” section of the Company’s
website at
https://investor.igmbio.com/news-and-events/events-and-presentations.
A replay of the webcast will be archived on the Company’s website
for 90 days following the presentation.
About IGM Biosciences, Inc. Headquartered
in Mountain View, California, IGM Biosciences is a
clinical-stage biotechnology company focused on creating and
developing engineered IgM antibodies. Since 2010, IGM
Biosciences has worked to overcome the manufacturing and
protein engineering hurdles that have limited the therapeutic use
of IgM antibodies. Through its efforts, IGM
Biosciences has created a proprietary IgM technology platform
for the development of IgM antibodies for those clinical
indications where their inherent properties may provide advantages
as compared to IgG antibodies.
Contact:
Argot Partners David Pitts212-600-1902
igmbio@argotpartners.com
IGM Biosciences (NASDAQ:IGMS)
Historical Stock Chart
From Mar 2024 to Apr 2024
IGM Biosciences (NASDAQ:IGMS)
Historical Stock Chart
From Apr 2023 to Apr 2024